Literature DB >> 33642231

The Japanese respiratory society guidelines for the management of cough and sputum (digest edition).

Hiroshi Mukae1, Takeshi Kaneko2, Yasushi Obase3, Masaharu Shinkai4, Toshio Katsunuma5, Kiyoshi Takeyama6, Jiro Terada7, Akio Niimi8, Hiroto Matsuse9, Kazuhiro Yatera10, Yoshihiro Yamamoto11, Arata Azuma12, Hirokazu Arakawa13, Takashi Iwanaga14, Haruhiko Ogawa15, Kiyoyasu Kurahashi16, Yasuhiro Gon17, Hirokazu Sakamoto18, Yoko Shibata19, Tsutomu Tamada20, Yasuhiko Nishioka21, Shusaku Haranaga22, Shigeharu Fujieda23, Naoyuki Miyashita24, Hiroyuki Mochizuki25, Akihito Yokoyama26, Shigemi Yoshihara27, Jun Tamaoki28.   

Abstract

Cough and sputum are common complaints at outpatient visits. In this digest version, we provide a general overview of these two symptoms and discuss the management of acute (up to three weeks) and prolonged/chronic cough (longer than three weeks). Flowcharts are provided, along with a step-by-step explanation of their diagnosis and management. Most cases of acute cough are due to an infection. In chronic respiratory illness, a cough could be a symptom of a respiratory infection such as pulmonary tuberculosis, malignancy such as a pulmonary tumor, asthma, chronic obstructive pulmonary disease, chronic bronchitis, bronchiectasis, drug-induced lung injury, heart failure, nasal sinus disease, sinobronchial syndrome, eosinophilic sinusitis, cough variant asthma (CVA), atopic cough, chronic laryngeal allergy, gastroesophageal reflux (GER), and post-infectious cough. Antibiotics should not be prescribed for over-peak cough but can be considered for atypical infections. The exploration of a single/major cause is recommended for persistent/chronic cough. When sputum is present, a sputum smear/culture (general bacteria, mycobacteria), cytology, cell differentiation, chest computed tomography (CT), and sinus X-ray or CT should be performed. There are two types of rhinosinusitis. Conventional sinusitis and eosinophilic rhinosinusitis present primarily with neutrophilic inflammation and eosinophilic inflammation, respectively. The most common causes of dry cough include CVA, atopic cough/laryngeal allergy (chronic), GER, and post-infectious cough. In the last chapter, future challenges and perspectives are discussed. We hope that the clarification of the pathology of cough hypersensitivity syndrome will lead to further development of "pathology-specific non-specific therapeutic drugs" and provide benefits to patients with chronic refractory cough.
Copyright © 2021 The Japanese Respiratory Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Atopic cough; Cough variant asthma; Gastroesophageal reflux disease; Infectious cough; Laryngeal allergy

Year:  2021        PMID: 33642231     DOI: 10.1016/j.resinv.2021.01.007

Source DB:  PubMed          Journal:  Respir Investig        ISSN: 2212-5345


  6 in total

1.  Impact of refractory and unexplained chronic cough on disease burden: a qualitative study.

Authors:  Naoya Ueda; Anzu Yakushiji; Jonathan Schelfhout; Shigeru Tokita; Takekazu Kubo
Journal:  BMC Pulm Med       Date:  2022-10-01       Impact factor: 3.320

2.  Efficacy of non-sedating H1-receptor antihistamines in adults and adolescents with chronic cough: A systematic review.

Authors:  Ji-Hyang Lee; Ji Won Lee; Jin An; Ha-Kyeong Won; So-Young Park; Ji-Ho Lee; Sung-Yoon Kang; Yoshihiro Kanemitsu; Hyun Jung Kim; Woo-Jung Song
Journal:  World Allergy Organ J       Date:  2021-07-21       Impact factor: 4.084

3.  Clinical and Inflammatory Characteristics of the Chinese APAC Cough Variant Asthma Cohort.

Authors:  Kefang Lai; Wenzhi Zhan; Feng Wu; Yunhui Zhang; Lin Lin; Wen Li; Fang Yi; Ziyu Jiang; Yuanrong Dai; Suyun Li; Jiangtao Lin; Yadong Yuan; Yong Jiang; Chen Qiu; Limin Zhao; Meihua Chen; Zhongmin Qiu; Hu Li; Ruchong Chen; Wei Luo; Jiaxing Xie; Chunxing Guo; Mei Jiang; Xiaohong Yang; Guochao Shi; Dejun Sun; Rongchang Chen; Kian Fan Chung; Huahao Shen; Nanshan Zhong
Journal:  Front Med (Lausanne)       Date:  2022-01-21

4.  Prevalence of chronic cough in China: a systematic review and meta-analysis.

Authors:  Hanwen Liang; Weiyan Ye; Zhufeng Wang; Jingyi Liang; Fang Yi; Mei Jiang; Kefang Lai
Journal:  BMC Pulm Med       Date:  2022-02-12       Impact factor: 3.317

5.  Randomised trial of the P2X3 receptor antagonist sivopixant for refractory chronic cough.

Authors:  Akio Niimi; Junpei Saito; Tadashi Kamei; Masaharu Shinkai; Hiroyuki Ishihara; Mitsuaki Machida; Sayaka Miyazaki
Journal:  Eur Respir J       Date:  2022-06-02       Impact factor: 33.795

6.  Non-pharmacological Management of Non-productive Chronic Cough in Adults: A Systematic Review.

Authors:  Ana Maria Ilicic; Ana Oliveira; Razanne Habash; Yejin Kang; Michelle Kho; Roger Goldstein; Dina Brooks
Journal:  Front Rehabil Sci       Date:  2022-05-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.